Shares of LendingTree, Inc. (NASDAQ:TREE – Get Free Report) have been assigned an average recommendation of “Buy” from the nine brokerages that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $64.13.
A number of equities research analysts recently commented on the stock. Wall Street Zen cut shares of LendingTree from a “buy” rating to a “hold” rating in a report on Sunday, May 11th. Stephens reaffirmed an “overweight” rating and issued a $69.00 price target on shares of LendingTree in a report on Thursday, March 6th. JPMorgan Chase & Co. lifted their price target on shares of LendingTree from $65.00 to $68.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Needham & Company LLC lowered their price target on shares of LendingTree from $65.00 to $62.00 and set a “buy” rating on the stock in a report on Friday, May 2nd. Finally, Keefe, Bruyette & Woods lowered their price target on shares of LendingTree from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, March 6th.
View Our Latest Research Report on LendingTree
LendingTree Price Performance
LendingTree (NASDAQ:TREE – Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The financial services provider reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.74 by $0.25. The company had revenue of $239.70 million for the quarter, compared to analysts’ expectations of $244.93 million. LendingTree had a negative net margin of 5.67% and a positive return on equity of 14.76%. The company’s revenue for the quarter was up 42.8% compared to the same quarter last year. On average, equities analysts anticipate that LendingTree will post 0.48 EPS for the current year.
Insider Buying and Selling at LendingTree
In other LendingTree news, General Counsel Heather Enlow-Novitsky sold 1,250 shares of the business’s stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $36.24, for a total transaction of $45,300.00. Following the sale, the general counsel now owns 2,028 shares of the company’s stock, valued at $73,494.72. The trade was a 38.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 23.40% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. New Age Alpha Advisors LLC bought a new position in shares of LendingTree in the fourth quarter worth $36,000. Tower Research Capital LLC TRC increased its holdings in shares of LendingTree by 248.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 1,190 shares of the financial services provider’s stock worth $46,000 after purchasing an additional 848 shares during the period. Wealthfront Advisers LLC bought a new position in shares of LendingTree in the fourth quarter worth $54,000. CANADA LIFE ASSURANCE Co bought a new position in shares of LendingTree in the fourth quarter worth $56,000. Finally, KLP Kapitalforvaltning AS bought a new position in shares of LendingTree in the fourth quarter worth $70,000. Institutional investors own 68.26% of the company’s stock.
About LendingTree
LendingTree, Inc, through its subsidiary, operates online consumer platform in the United States. It operates through three segments: Home, Consumer, and Insurance. The Home segment offers purchase mortgage, refinance mortgage, and home equity loans and lines of credit; and real estate brokerage services.
Featured Stories
- Five stocks we like better than LendingTree
- Bank Stocks – Best Bank Stocks to Invest In
- AutoNation: Growth Engines Make It an Undervalued Stock
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Snowflake Hits 52-Week High—Options Traders Bet on Further Rally
- Using the MarketBeat Dividend Tax Calculator
- 3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
Receive News & Ratings for LendingTree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LendingTree and related companies with MarketBeat.com's FREE daily email newsletter.